Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: J01DH04

Doribax(doripenem)

Pneumonia, Ventilator-Associated;Pneumonia, Bacterial;Urinary Tract Infections;Bacterial Infections;Cross Infection

Marketing Authorisation Holder: Janssen-Cilag International NV

EMA Authorisation: 25/07/2008

INN: doripenem

Indication

Doribax is indicated for the treatment of the following infections in adults: nosocomial pneumonia (including ventilator-associated pneumonia); complicated intra-abdominal infections; complicated urinary tract infections. Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Doribax — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.